SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-17-240776
Filing Date
2017-07-31
Accepted
2017-07-28 17:34:56
Documents
4
Group Members
FHM LIFE SCIENCES VIII, L.L.C.FHM LIFE SCIENCES VIII, L.P.JAMES TOPPERPATRICK J. HERON

Document Format Files

Seq Description Document Type Size
1 SC 13D d435124dsc13d.htm SC 13D 117730
2 EX-99.A d435124dex99a.htm EX-99.A 9168
3 EX-99.B d435124dex99b.htm EX-99.B 5236
4 EX-99.C d435124dex99c.htm EX-99.C 24919
  Complete submission text file 0001193125-17-240776.txt   158910
Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Subject) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88896 | Film No.: 17991026
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101 206-254-7200
Frazier Life Sciences VIII, L.P. (Filed by) CIK: 0001655827 (see all company filings)

IRS No.: 475290848 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D